Erwin A. Kruger

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.

W D Figg, William Dahut, Paul H. Duray et al. · PubMed · 2001 · 304 citations

Medicine, Pharmacology, Pharmacotherapy +13

The Angiogenesis Inhibitor, Endostatin, Does Not Affect Murine Cutaneous Wound Healing

Adam C. Berger, Andrew L. Feldman, Michael Gnant et al. · Journal of Surgical Research · 2000 · 107 citations

Medicine, Dermatology, Surgery +9

Endothelial Monocyte Activating Polypeptide II Induces Endothelial Cell Apoptosis and May Inhibit Tumor Angiogenesis

Adam C. Berger, H. Richard Alexander, Guangquing Tang et al. · Microvascular Research · 2000 · 95 citations

Medicine, Cancer Biology, Oncology +12

Endostatin Inhibits Microvessel Formation in the ex Vivo Rat Aortic Ring Angiogenesis Assay

Erwin A. Kruger, Paul H. Duray, Maria Tsokos et al. · Biochemical and Biophysical Research Communications · 2000 · 93 citations

Life Sciences, Cell Biology, Pharmacology +9

Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.

Sylvia S. W. Ng, Michael Gütschow, Sunna Hauschildt et al. · PubMed · 2003 · 85 citations

Medicine, Medicinal Chemistry, Pharmacology +12